Compare IMCR & TOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMCR | TOP |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United Kingdom | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2016 | 2021 |
| Metric | IMCR | TOP |
|---|---|---|
| Price | $29.68 | $15.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $62.73 | N/A |
| AVG Volume (30 Days) | ★ 364.8K | 86.4K |
| Earning Date | 11-05-2026 | 07-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 30.39 | ★ 81.25 |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $249,428,000.00 | $4,723,765.00 |
| Revenue This Year | $13.06 | N/A |
| Revenue Next Year | $8.12 | N/A |
| P/E Ratio | $132.78 | ★ N/A |
| Revenue Growth | ★ 43.05 | 41.89 |
| 52 Week Low | $27.56 | $0.61 |
| 52 Week High | $40.71 | $17.42 |
| Indicator | IMCR | TOP |
|---|---|---|
| Relative Strength Index (RSI) | 28.05 | 62.68 |
| Support Level | $27.66 | $14.34 |
| Resistance Level | $30.21 | $16.20 |
| Average True Range (ATR) | 1.17 | 0.77 |
| MACD | -0.20 | -0.23 |
| Stochastic Oscillator | 5.03 | 63.94 |
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
TOP Financial Group Ltd is operates as an online brokerage firm in Hong Kong specializing in the trading of local and overseas equities, futures, and options products. It conduct the futures and stock brokerage business through three trading platforms, Esunny for futures trading and Longbridge for stock trading, all of which were licensed from third parties and can be easily accessed through its application, or APP, software, and websites. The three platforms are designed for seamless, efficient, and secure trading platform. The company operates and manages its business as a single operating and reportable segment.